Abstract
RTOG protocols have proposed limiting doses to the Organs At Risk (OAR) for patients undergoing IMRT to the head-and-neck region. While efforts have focused on evaluating spinal cord tolerance when treating spinal column metastases, no recommendations exist for other adjacent OAR such as the brachial plexus or oropharyngeal region when performing spine radiosurgery (SRS) in the cervico-thoracic region. We evaluated the dosimetry as well as the acute and delayed effects of SRS to these adjacent but less well studied regions.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
